U.S. buys 600,000 doses of new COVID treatment still awaiting FDA approval
(HealthDay)—The U.S. government has bought 600,000 doses of a new antibody drug called bebtelovimab that seems able to beat back
Read more(HealthDay)—The U.S. government has bought 600,000 doses of a new antibody drug called bebtelovimab that seems able to beat back
Read moreSACRAMENTO, Calif. (AP) — A lawsuit over high health care bills filed on behalf of more than 3 million employers
Read moreMore nursing homes are waiting longer for covid-19 test results for residents and staffers, according to federal data, making the
Read moreWritten by Alex Sims What if the problem is not how we feel, but how we feel about our feelings?
Read moreAs many as half a million Australians are suffering from constant tinnitus, with farmers, automotive workers, transport drivers, construction workers
Read moreCovid: Infectious people 'should mix' says professor We use your sign-up to provide content in ways you’ve consented to and
Read more(Reuters Health) – Acute hospital patients 75 years and older may experience less functional decline and perceived pain when they
Read moreIf the United States ignores COVID-19 in Nigeria, we forgo global genomic surveillance at our own peril, reports a new
Read more(HealthDay)—Sleep-disordered breathing (SDB) in pregnancy is associated with an increased risk for metabolic syndrome (MetS) and hypertension (HTN) after delivery,
Read moreA cloud-based repository that creates a digital fingerprint of engineered microorganisms has been successfully trialed. An international team led by
Read more